With the gradual release of 2024 fund annual reports, the lineup of publicly offered funds' hidden heavy-weight stocks is coming into sharper focus. Ge Lan's funds continue to maintain substantial holdings in the innovative drug and medical device sectors. Zhou Weiwen has adopted a diversified investment approach, spanning industries such as banking, insurance, aviation, and gaming, and has voiced optimism for the AI market in his 2025 annual report. Meanwhile, Fu Pengbo retains a high concentration of shareholding and announces that future investment research will place greater emphasis on the technology sector. Hidden heavy-weight stocks have consistently been a pivotal aspect of fund annual reports, offering insight into fund managers' investment strategies. As we look ahead to 2025, numerous prominent fund managers are recalibrating their strategies to concentrate on emerging industries and innovative technologies, thereby indicating the market's investment trajectory.